FAQ

Phosphate Binder [EPC]

Known as: Phosphate Binder 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2017
024620052017

Related topics

Related topics

1 relation
Phosphate Binders

Related mentions per year

Related mentions per year

2005-2018
20002005201020152020
Phosphate Binder [EPC]
Phosphate Binders

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis: Phase 3 Randomized Trial.
Currently, calcium- or metal-containing phosphate binders are available to treat hyperphosphatemia in predialysis patients with… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2015
2015
Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.
Ferric citrate (FC) is a phosphate binder with shown efficacy and additional effects on iron stores and use of intravenous (iv… (More)
Is this relevant?
2015
2015
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
BACKGROUND Phosphate binders are the cornerstone of hyperphosphatemia management in dialysis patients. Ferric citrate is an iron… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
  • table 4
Is this relevant?
2015
2015
Feasibility study of colestipol as an oral phosphate binder in hemodialysis patients.
BACKGROUND Currently available calcium- and aluminium-based phosphate binders are dose limited because of potential toxicity, and… (More)
Is this relevant?
2014
2014
A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis.
BACKGROUND JTT-751 is a novel phosphate binder containing ferric citrate as the active ingredient. METHODS In this Phase 3… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
Reduction of costs for anemia-management drugs associated with the use of ferric citrate
BACKGROUND Ferric citrate is a novel phosphate binder which has the potential to reduce usage of erythropoietin-stimulating… (More)
Is this relevant?
2014
2014
Cost-minimization analysis of lanthanum carbonate versus sevelamer hydrochloride in US patients with end-stage renal disease.
PURPOSE Sevelamer hydrochloride (SH) and lanthanum carbonate (LC) are calcium-free phosphate binders used in the clinical… (More)
  • table I
  • table II
  • figure 1
  • figure 2
  • table IV
Is this relevant?
2014
2014
The utility of the phosphate binder, ferric citrate hydrate (JTT-751), about phosphorus absorption-reducing effect in normal rats.
Hyperphosphatemia is a risk factor for arterial calcification contributing to the high-cardiovascular mortality in patients with… (More)
Is this relevant?
2014
2014
Real-world dose-relativity, tablet burden, and cost comparison of conversion between sevelamer hydrochloride/carbonate and lanthanum carbonate monotherapies.
PURPOSE Sevelamer hydrochloride/carbonate (SH/C) and lanthanum carbonate (LC) are noncalcium-based phosphate binders used for the… (More)
Is this relevant?
2013
2013
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study
BACKGROUND Different phosphate binders exert differing effects on bone mineral metabolism and levels of regulating hormones. The… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?